Scoopfeeds — Intelligent news, curated.
UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals
tech

UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals

Bloomberg Tech · Jun 24, 2026, 7:57 AM · Also reported by 1 other source

UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler discusses the factors behind the tech selloff and where he sees value in markets. "You're going to get volatility — this isn't the first time we've seen this," Fowler tells Bloomberg Television. "It's an artifice of market struc

Read full story on Bloomberg Tech → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop